Trial Profile
An open label, Phase II, Clinical Study to evaluate the efficacy and tolerability of Arnophyte Cream formulation for pain reduction in patients with recurrent genital herpes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jan 2020
Price :
$35
*
At a glance
- Drugs Arnophyte (Primary)
- Indications Herpes genitalis; Herpes simplex virus type 2 infections; Pain
- Focus Therapeutic Use
- Sponsors Piramal Enterprises
- 25 Jun 2018 New trial record